Breast CancerФаза 2NCT02476786
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
FACT-B, Goserelin, Anastrozole, Exemestane
63 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Breast63 studies
Breast CancerФаза 2NCT02476786
FACT-B, Goserelin, Anastrozole, Exemestane
Locoregional RecurrenceФаза 2NCT05467891
Ribociclib, Fulvestrant, Anastrozole, Letrozole
Breast CancerФаза 2NCT06695845
Zanidatamab
Breast CancerФаза 2NCT07694986
cDC1 Vaccine, Trastuzumab, Nivolumab
Breast CancerФаза 2NCT06444269
Radiomics on MRI, microbubble CEUS Contrast Enhanced Ultrasound (CEUS)
Metastatic HER2-Negative Breast CarcinomaФаза 2NCT05770531
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Sacituzumab Govitecan
Anatomic Stage I Breast Cancer AJCC v8Фаза 2NCT07158021
Biospecimen Collection, Electronic Health Record Review, Goserelin, Leuprolide
Metastatic HER2-Negative Breast CancerPhase 1NCT05029999
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
PTEN-Altered Advanced Solid Tumors and HER2-Negative Breast CancerPhase 1NCT04997993
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
Breast CancerФаза 2NCT03936478
MRIdian Radiation Treatment Unit
HR-Positive, HER2-Low or Ultralow Metastatic Breast CancerPhase 1/2NCT07198724
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
Triple Negative Breast CancerPhase 1NCT05504707Papers
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
Triple-Negative Breast CancerPhase 1NCT06324240
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
Advanced ER-Positive HER2-Negative Breast CancerPhase 1NCT05900895
Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
Metastatic Hormone Receptor-Positive Breast CancerPhase 1NCT07137871
Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy